Hikma Pharmaceuticals

Hikma is a multinational pharmaceutical group dedicated to improving the health and wellbeing of people in the markets it serves through the development, manufacturing and marketing of a broad range of solid, liquid and injectable generic and in-licensed pharmaceutical products.
Hikma is a leading generic pharmaceutical company with a significant presence in the Middle East and North Africa (MENA) region, the United States and Europe. It was first listed on the London Stock Exchange in 2005 is now a constituent of the FTSE 100 Index.

Type
Public
HQ
London, GB
Founded
1978
Employees
7,189 (est)

Hikma Pharmaceuticals Locations

London, GB
Beirut, LB
Cairo, EG
Dubai, AE
Riyadh, SA

Hikma Pharmaceuticals Metrics

Hikma Pharmaceuticals Summary

Founding Date

1978

Market capitalization

£3.77 B

Closing share price

£16.7

Hikma Pharmaceuticals Market Value History

Hikma Pharmaceuticals Online Presence

Hikma Pharmaceuticals News

Hikma Pharmaceuticals Company Life

You may also be interested in